Discover the 6 major orthopedic practice acquisitions of 2023 with Provident s "Mergers and Acquisitions Update" report. Notable acquisitions include InTandem C
Share:
NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (NASDAQ:PAVM, PAVMZ)) (the Company or PAVmed ), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that the first U.S. patient recently underwent successful carpal tunnel release using its CarpX
® minimally invasive carpal tunnel device.
CarpX relieves the symptoms of Carpal Tunnel Syndrome (CTS) in a rapid, minimally invasive, office-based procedure that speeds patients recovery. CTS is a common workplace-related condition that causes chronic pain to patients and, as the top driver of workmen s compensation claims, imposes high costs on society.
The patient presented with symptoms of carpal tunnel syndrome to Dr. Edward J. Armbruster of Mercer-Bucks Orthopaedics, P.C., in greater Philadelphia, who performed minimally invasive carpal tunnel release using the CarpX device. In marked contrast to typical recovery times of up to several months following conventiona